Source: Eur Respir J 2010; 36: 549-555
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Humbert M., Sitbon O., Yaïci A., Montani D., O'Callaghan D.S., Jaïs X., Parent F., Savale L., Natali D., Günther S., Chaouat A., Chabot F., Cordier J-F., Habib G., Gressin V., Jing Z-C., Souza R., Simonneau G.. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J 2010; 36: 549-555

Member's Comments

No comment yet.

Related content which might interest you: Prognostic predictors in younger and older incident idiopathic pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology Year: 2013 Characteristics of Japanese elderly patients with pulmonary arterial hypertension Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019 Survival and prognostic factors in patients with incident systemic sclerosis-associated pulmonary arterial hypertension from the French registry Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 Hospitalization in patients with pulmonary arterial hypertension: causes and outcomes Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Survival in patients with different groups of pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries Year: 2012 Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Comparison of prevalence of diabetes mellitus in patients with idiopathic pulmonary arterial hypertension and distal chronic thromboembolic pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Eur Respir J 2005; 26: Suppl. 49, 272s Year: 2005 Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN Source: Eur Respir J 2015; 46: 1711-1720 Year: 2015 Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Survival in medically treated chronic thromboembolic pulmonary hypertension patients Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension Year: 2018 Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension Source: ERJ Open Res, 6 (4) 00299-2020; 10.1183/23120541.00299-2020 Year: 2020 Cancer incidence in incident patients with precapillary pulmonary hypertension. Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease in the French PAH registry Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Survival of patients with schistosomiasis-associated pulmonary arterial hypertension in the modern management era Source: Eur Respir J, 51 (6) 1800307; 10.1183/13993003.00307-2018 Year: 2018 The prevalence of pulmonary hypertension and the related factors in hemodialysis patients Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 A critical analysis of survival in pulmonary arterial hypertension Source: Eur Respir Rev 2012 21:218-222 Year: 2012 Effect of long-term specific therapy in a cohort of 33 patients with pulmonary arterial hypertension of various etiologies Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019 Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020